Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v3.20.1
Condensed Consolidated Statements of Cash Flows - USD ($)
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Cash Flows From Operating Activities:    
Net loss $ (2,990,000) $ (3,528,000)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation 83,000 64,000
Subsidiary stock issues to vendor 26,000 16,000
Depreciation 58,000 62,000
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets 297,000 (267,000)
Right of use asset 33,000 28,000
Accounts payable (1,068,000) (267,000)
Accrued expenses (714,000) 711,000
Accrued employee benefits (626,000) (991,000)
Lease liability (59,000) (52,000)
Net Cash Used In Operating Activities (4,960,000) (4,224,000)
Cash Flows From Investing Activities:    
Net Cash From Investing Activities 0 0
Cash Flows From Financing Activities:    
Net Cash From Financing Activities 0 0
Net decrease in cash and cash equivalents (4,960,000) (4,224,000)
Cash and cash equivalents at beginning of period 15,045,000 28,918,000
Cash and cash equivalents at end of period 10,085,000 24,694,000
Noncash Financing Activities:    
Right of use asset from operating lease 0 538,000
Deemed dividends for accretion of Series B Preferred Stock discount 404,000 398,000
In-kind dividends paid in preferred stock 62,000 61,000
Series B Preferred Stock [Member]    
Noncash Financing Activities:    
Conversion of Series B Preferred Stock $ 669,000 $ 638,000